Venus Glow for Alopecia

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
University of Minnesota, Minneapolis, MN
Alopecia+2 More
Venus Glow - Device
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

The study will be focused on evaluating the use of hydradermabrasion on the scalp. The study aims to assess the effect of this treatment on scalp health and hair growth.

Eligible Conditions

  • Alopecia
  • Androgenetic Alopecia

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: Assessed at Visit 8

Assessed at Visit 8
Hair Changes
Scalp Health- ASFS
Scalp Health- Erythema
Scalp Health- Folliculitis

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

1 Treatment Group

Treatment
1 of 1
Experimental Treatment

40 Total Participants · 1 Treatment Group

Primary Treatment: Venus Glow · No Placebo Group · Phase 4

Treatment
Device
Experimental Group · 1 Intervention: Venus Glow · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: assessed at visit 8
Closest Location: University of Minnesota · Minneapolis, MN
Photo of University of Minnesota  1Photo of University of Minnesota  2Photo of University of Minnesota 3
1993First Recorded Clinical Trial
15 TrialsResearching Alopecia
830 CompletedClinical Trials

Who is running the clinical trial?

University of MinnesotaLead Sponsor
1,227 Previous Clinical Trials
1,454,363 Total Patients Enrolled
10 Trials studying Alopecia
240 Patients Enrolled for Alopecia
Ronda FarahPrincipal InvestigatorUniversity of Minnesota

Eligibility Criteria

Age 18+ · All Participants · 7 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are willing to attend the required study visits.
You are a healthy male or female aged 18 - 65 years.
You agree to use the same shampoo for the duration of the study.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.